18-47841859-A-T

Position:

• chr18-47841859-A-T

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 5P and 1B. PM1 PM2 PP2 BP4

The NM_005901.6(SMAD2):​c.1372T>A​(p.Ser458Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: not found (cov: 32)
• Consequence: SMAD2 NM_005901.6 missense
• Clinical Significance: Uncertain significance criteria provided, single submitter U:1
• Conservation: PhyloP100: 7.37

Genes affected

SMAD2 (HGNC:6768): (SMAD family member 2) The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signal of the transforming growth factor (TGF)-beta, and thus regulates multiple cellular processes, such as cell proliferation, apoptosis, and differentiation. This protein is recruited to the TGF-beta receptors through its interaction with the SMAD anchor for receptor activation (SARA) protein. In response to TGF-beta signal, this protein is phosphorylated by the TGF-beta receptors. The phosphorylation induces the dissociation of this protein with SARA and the association with the family member SMAD4. The association with SMAD4 is important for the translocation of this protein into the nucleus, where it binds to target promoters and forms a transcription repressor complex with other cofactors. This protein can also be phosphorylated by activin type 1 receptor kinase, and mediates the signal from the activin. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, May 2012]

ACMG classification

Verdict is Uncertain_significance. Variant got 4 ACMG points.

• PM1: In a domain MH2 (size 193) in uniprot entity SMAD2_HUMAN there are 8 pathogenic changes around while only 0 benign (100%) in NM_005901.6
• PM2: Very rare variant in population databases, with high coverage
• PP2: Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SMAD2. . Gene score misZ 3.6626 (greater than the threshold 3.09). Trascript score misZ 4.4705 (greater than threshold 3.09). GenCC has associacion of gene with Loeys-Dietz syndrome 6, congenital heart disease, familial thoracic aortic aneurysm and aortic dissection, Loeys-Dietz syndrome, congenital heart defects, multiple types, 8, with or without heterotaxy.
• BP4: Computational evidence support a benign effect (MetaRNN=0.31579602).

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
SMAD2	NM_005901.6	c.1372T>A	p.Ser458Thr	missense_variant	11/11	ENST00000262160.11	NP_005892.1
SMAD2	NM_001003652.4	c.1372T>A	p.Ser458Thr	missense_variant	11/11		NP_001003652.1
SMAD2	NM_001135937.3	c.1282T>A	p.Ser428Thr	missense_variant	10/10		NP_001129409.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
SMAD2	ENST00000262160.11	c.1372T>A	p.Ser458Thr	missense_variant	11/11	1	NM_005901.6	ENSP00000262160.6
SMAD2	ENST00000402690.6	c.1372T>A	p.Ser458Thr	missense_variant	11/11	1		ENSP00000384449.1
SMAD2	ENST00000356825.8	c.1282T>A	p.Ser428Thr	missense_variant	10/10	1		ENSP00000349282.4
SMAD2	ENST00000586040.5	c.1282T>A	p.Ser428Thr	missense_variant	9/9	5		ENSP00000466193.1

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome Cov.: 31

GnomAD4 genome Cov.: 32

ClinVar

Significance: Uncertain significance

Submissions summary: Uncertain:1

Revision: criteria provided, single submitter

Submissions by phenotype

Inborn genetic diseases Uncertain:1

Uncertain significance, criteria provided, single submitter

clinical testing

Ambry Genetics

Aug 27, 2024

The c.1372T>A (p.S458T) alteration is located in exon 11 (coding exon 10) of the SMAD2 gene. This alteration results from a T to A substitution at nucleotide position 1372, causing the serine (S) at amino acid position 458 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Benign	0.27
BayesDel_addAF	Pathogenic	0.26	D
BayesDel_noAF	Uncertain	0.13
CADD	Uncertain	24
DANN	Uncertain	0.98
DEOGEN2	Uncertain	0.77	D;D;.;.
Eigen	Uncertain	0.35
Eigen_PC	Uncertain	0.47
FATHMM_MKL	Pathogenic	1.0	D
LIST_S2	Uncertain	0.91	.;D;D;.
M_CAP	Uncertain	0.12	D
MetaRNN	Benign	0.32	T;T;T;T
MetaSVM	Pathogenic	0.90	D
MutationAssessor	Uncertain	2.7	M;M;.;.
PrimateAI	Uncertain	0.70	T
PROVEAN	Benign	-2.2	N;N;N;.
REVEL	Pathogenic	0.68
Sift	Benign	0.047	D;D;T;.
Sift4G	Uncertain	0.034	D;D;D;D
Polyphen		0.43	B;B;B;B
Vest4		0.25
MutPred		0.37		Loss of disorder (P = 0.0682);Loss of disorder (P = 0.0682);.;.;
MVP		0.90
MPC		1.0
ClinPred		0.80	D
GERP RS		5.7
Varity_R		0.53
gMVP		0.97

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr18-45368230;